Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX)

Journal of Cellular Biochemistry

Volumn 115, Issue 7, 2014, Pages 1254-1261

  Hiroshima, Yukihiko ^a,b,c   Zhao, Ming ^a   Maawy, Ali ^b   Zhang, Yong ^a   Katz, Matthew H G ^d   Fleming, Jason B ^d   Uehara, Fuminari ^a,b   Miwa, Shinji ^a,b   Yano, Shuya ^a,b   Momiyama, Masashi ^c   Suetsugu, Atsushi ^e   Chishima, Takashi ^c   Tanaka, Kuniya ^c   Bouvet, Michael ^b   Endo, Itaru ^c   Hoffman, Robert M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e GIFU UNIVERSITY   (Japan)

Author keywords

FLUORESCENT PROTEINS; IMAGING; NUDE MICE; ORTHOTOPIC; PANCREATIC CANCER; PDOX; RFP; Salmonella typhimurium

Indexed keywords

A1 R; CISPLATIN; FLUOROURACIL; GEMCITABINE; NATURAL PRODUCT; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; PHOTOPROTEIN; RED FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM; CANCER CHEMOTHERAPY; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOCLAST; PANCREAS CANCER; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; STROMA CELL; TREATMENT RESPONSE; TUMOR VOLUME; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; DISEASE MODEL; DRUG SCREENING; GENETICS; NUDE MOUSE; PANCREATIC NEOPLASMS; PATHOGENICITY; PATHOLOGY; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SCID MOUSE; XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CISPLATIN; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; FLUOROURACIL; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; MICE, SCID; PANCREATIC NEOPLASMS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84900029102     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24769     Document Type: Article

References (42)

1. Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, Corà D, Di Nicolantonio F, Buscarino M, Petti C, Ribero D, Russolillo N, Muratore A, Massucco P, Pisacane A, Molinaro L, Valtorta E, Sartore-Bianchi A, Risio M, Capussotti L, Gambacorta M, Siena S, Medico E, Sapino A, Marsoni S, Comoglio PM, Bardelli A, Trusolino L,. 2011. A molecularly annotated platform of patient-derived xenografts (xenopatients) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov 1: 508-523.
2. Bouvet M, Yang M, Nardin S, Wang X, Jiang P, Baranov E, Moossa AR, Hoffman RM,. 2000. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models. Clin Exp Metastasis 18: 213-218.
3. Bouvet M, Wang J-W, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR, Hoffman RM,. 2002. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62: 1534-1540.
4. Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC,. 1992. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127: 1335-1339.
5. Fidler IJ,. 1990. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50: 6130-6138.
6. Flentie K, Kocher B, Gammon ST, Novack DV, McKinney JS, Piwnica-Worms D,. 2012. A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy. Cancer Discov 2: 624-637.
7. Forbes NS,. 2010. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 10: 785-794.
8. Fu XY, Besterman JM, Monosov A, Hoffman RM,. 1991. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA 88: 9345-9349.
9. Fu X, Guadagni F, Hoffman RM,. 1992. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA 89: 5645-5649.
10. Fu X, Hoffman RM,. 1993. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res 13: 283-286.
11. Fu X, Le P, Hoffman RM,. 1993. A metastatic-orthotopic transplant nude-mouse model of human patient breast cancer. Anticancer Res 13: 901-904.
12. Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM,. 1993a. A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 53: 3070-3072.
13. Furukawa T, Fu X, Kubota T, Watanabe M, Kitajima M, Hoffman RM,. 1993b. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res 53: 1204-1208.
14. Gerber K,. 2009. From Human to mouse and back: "Tumorgraft" models surge in popularity. J Natl Cancer Inst 101: 6-8.
15. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Hoffman RM,. 2009a. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 106: 992-998.
16. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Kishimoto H, Bouvet M, Hoffman RM,. 2009b. Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 8: 870-875.
17. Hiroshima Y, Zhao M, Zhang Y, Maawy A, Hassanein MK, Uehara F, Miwa S, Yano S, Momiyama M, Suetsugu A, Chishima T, Tanaka K, Bouvet M, Endo I, Hoffman RM,. 2013. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle 12: 2774-2780.
18. Hoffman RM,. 1999. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic. Invest New Drugs 17: 343-359.
19. Hoffman RM,. 2012. Bugging tumors. Cancer Discov 2: 588-590.
20. Jia LJ, Wei DP, Sun QM, Huang Y, Wu Q, Hua ZC,. 2007. Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models. Cancer Sci 98: 1107-1112.
21. Katz M, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M,. 2003. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113: 151-160.
22. Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE,. 2009. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc 4: 1670-1680.
23. Kim MP, Truty MJ, Choi W, Kang Y, Chopin-Lally X, Gallick GE, Wang H, McConkey DJ, Hwang R, Logsdon C, Abbruzzesse J, Fleming JB,. 2012. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Ann Surg Oncol 19 (Suppl 3): S395-S403.
24. Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, Bouvet M, Wessels J, Hoffman RM,. 2010. Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif 43: 41-48.
25. Momiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, Endo I, Hoffman RM,. 2012. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 11: 628-632.
26. Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Hoffman RM,. 2009. Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 29: 1873-1878.
27. Nauts HC, Fowler GA, Bogatko FH,. 1953. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med Scand Suppl 145: 1-102.
28. Pawelek JM, Low KB, Bermudes D,. 2003. Bacteria as tumour-targeting vectors. Lancet Oncol 4: 548-556.
29. Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Moriwaki H, Bouvet M, Saji S, Hoffman RM,. 2012a. Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens. J Cell Biochem 113: 2290-2295.
30. Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Saji S, Moriwaki H, Bouvet M, Hoffman RM,. 2012b. Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens. Anticancer Res 32: 1175-1180.
31. Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Saji S, Moriwaki H, Bouvet M, Hoffman RM,. 2012c. Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice. Anticancer Res 32: 3063-3067.
32. Talmadge JE, Singh RK, Fidler IJ, Raz A,. 2007. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170: 793-804.
33. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, Seipp C, Haworth L, Mavroukakis S, White D, MacDonald S, Mao J, Sznol M, Rosenberg SA,. 2002. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20: 142-152.
34. Uchugonova A, Hoffman RM, Weinigel M, Koenig K,. 2011. Watching stem cells in the skin of living mice noninvasively. Cell Cycle 10: 2017-2020.
35. Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A,. 2004. Mouse in red: Red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 40: 241-246.
36. Yam C, Zhao M, Hayashi K, Ma H, Kishimoto H, McElroy M, Bouvet M, Hoffman RM,. 2010. Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 164: 248-255.
37. Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM,. 2006. Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res 66: 4208-4214.
38. Yang M, Reynoso J, Bouvet M, Hoffman RM,. 2009. A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment. J Cell Biochem 106: 279-284.
39. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM,. 2005. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 102: 755-760.
40. Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z, Hoffman RM,. 2006. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66: 7647-7652.
41. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM,. 2007. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 104: 10170-10174.
42. Zhao M, Suetsugu A, Ma H, Zhang L, Liu F, Zhang Y, Tran B, Hoffman RM,. 2012. Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice. Cell Cycle 11: 187-193.